Jazz Pharmaceuticals raises $1.25 billion via 2032 exchangeable notes
Jazz Pharmaceuticals raised $1.25 billion through 1.875% exchangeable notes due 2032.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.